Your browser doesn't support javascript.
loading
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.
Bousquet, J; Onorato, G L; Bachert, C; Barbolini, M; Bedbrook, A; Bjermer, L; de Sousa, J Correia; Chavannes, N H; Cruz, A A; De Manuel Keenoy, E; Devillier, P; Fonseca, J; Hun, S; Kostka, T; Hellings, P W; Illario, M; Ivancevich, J C; Larenas-Linnemann, D; Millot-Keurinck, J; Ryan, D; Samolinski, B; Sheikh, A; Yorgancioglu, A; Agache, I; Arnavielhe, S; Bewick, M; Annesi-Maesano, I; Anto, J M; Bergmann, K C; Bindslev-Jensen, C; Bosnic-Anticevich, S; Bouchard, J; Caimmi, D P; Camargos, P; Canonica, G W; Cardona, V; Carriazo, A M; Cingi, C; Colgan, E; Custovic, A; Dahl, R; Demoly, P; De Vries, G; Fokkens, W J; Fontaine, J F; Gemicioglu, B; Guldemond, N; Gutter, Z; Haahtela, T; Hellqvist-Dahl, B.
Afiliação
  • Bousquet J; Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Onorato GL; INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
  • Bachert C; CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
  • Barbolini M; Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Bedbrook A; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
  • Bjermer L; Regione Emilia Romagna - Agenzia Sanitaria e Sociale, Reference Site of the European Innovation Partnership on Healthy and Active Ageing, Bologna, Italy.
  • de Sousa JC; Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Chavannes NH; Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden.
  • Cruz AA; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
  • De Manuel Keenoy E; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Devillier P; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil.
  • Fonseca J; GARD Executive Committee, Salvador, Brazil.
  • Hun S; Kronikgune, International Centre of Excellence in Chronicity Research Barakaldo, Bizkaia Bilbao, Spain.
  • Kostka T; Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Versailles, France.
  • Hellings PW; Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
  • Illario M; Allergy Unit, CUF Porto Instituto and Hospital, Porto, Portugal.
  • Ivancevich JC; Public Health Agency Northern Ireland, Belfast, UK.
  • Larenas-Linnemann D; Department of Geriatrics, Medical University of Lodz, Healthy Ageing Research Centre (HARC), Lodz, Poland.
  • Millot-Keurinck J; Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
  • Ryan D; Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
  • Samolinski B; Allergy and Immunology Department, Santa Isabel, Buenos Aires, Argentina.
  • Sheikh A; Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico, Mexico.
  • Yorgancioglu A; Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR), 34000 Montpellier, France.
  • Agache I; Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
  • Arnavielhe S; Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
  • Bewick M; Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
  • Annesi-Maesano I; Department of Pulmonology, Celal Bayar University, Manisa, Turkey.
  • Anto JM; GARD Executive Committee, Manisa, Turkey.
  • Bergmann KC; Faculty of Medicine, Transylvania University, Brasov, Romania.
  • Bindslev-Jensen C; Kyomed, Montpellier, France.
  • Bosnic-Anticevich S; iQ4U Consultants Ltd, London, UK.
  • Bouchard J; EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France.
  • Caimmi DP; Centre for Research in Environmental Epidemiology (CREAL), ISGLoBAL, Barcelona, Spain.
  • Camargos P; IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
  • Canonica GW; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Cardona V; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Carriazo AM; Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Cingi C; Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
  • Colgan E; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
  • Custovic A; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
  • Dahl R; Personalized Medicine Clinic Asthma and Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan Italy.
  • Demoly P; Laval's University, Quebec City, Canada.
  • De Vries G; Hôpital de la Malbaie, Quebec City, Canada.
  • Fokkens WJ; CHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
  • Fontaine JF; Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
  • Gemicioglu B; Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Guldemond N; CHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
  • Gutter Z; Allergologia, S Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
  • Haahtela T; Regional Ministry of Health of Andalusia, Seville, Spain.
  • Hellqvist-Dahl B; ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
Clin Transl Allergy ; 7: 37, 2017.
Article em En | MEDLINE | ID: mdl-29075437
ABSTRACT
A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França